Maximising the impact of inactivated polio vaccines.
作者信息
Brickley Elizabeth B, Wright Peter F
机构信息
Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.
出版信息
Lancet Infect Dis. 2017 Jul;17(7):680-681. doi: 10.1016/S1473-3099(17)30236-0. Epub 2017 Apr 25.
Abstract
摘要
相似文献
1
Maximising the impact of inactivated polio vaccines.最大化灭活脊髓灰质炎疫苗的影响。
Lancet Infect Dis. 2017 Jul;17(7):680-681. doi: 10.1016/S1473-3099(17)30236-0. Epub 2017 Apr 25.
2
New, less-expensive inactivated polio vaccine non-inferior to conventional inactivated vaccine.
J Pediatr. 2019 Sep;212:241-242. doi: 10.1016/j.jpeds.2019.07.009.
3
Decision analysis in planning for a polio outbreak in the United States.美国脊髓灰质炎疫情应对规划中的决策分析
Pediatrics. 2006 Aug;118(2):611-8. doi: 10.1542/peds.2005-2358.
4
Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines.口服脊髓灰质炎疫苗和强化效力灭活脊髓灰质炎疫苗的血清学反应。
Am J Epidemiol. 1988 Sep;128(3):615-28. doi: 10.1093/oxfordjournals.aje.a115009.
5
Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.以色列针对强化灭活脊髓灰质炎疫苗/口服脊髓灰质炎疫苗序贯接种计划的免疫反应：对脊髓灰质炎控制的影响
Vaccine. 1998 Dec;16(20):2090-5. doi: 10.1016/s0264-410x(98)00071-1.
6
Role of EIPV in 1988 Israel polio outbreak.1988年以色列脊髓灰质炎疫情中环境感染性脊髓灰质炎病毒的作用。
Vaccine. 1994 Apr;12(5):476. doi: 10.1016/0264-410x(94)90130-9.
7
Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.在日本开发和引进源自 Sabin 株的脊髓灰质炎灭活疫苗。
Vaccine. 2016 Apr 7;34(16):1975-85. doi: 10.1016/j.vaccine.2014.11.015. Epub 2014 Nov 21.
8
Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.用灭活脊髓灰质炎病毒疫苗进行初次免疫后对口服脊髓灰质炎病毒疫苗的中和抗体反应。
Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):815-6. doi: 10.1007/s100960050198.
9
The historical feud over polio vaccine: how could a killed vaccine contain a natural disease?关于脊髓灰质炎疫苗的历史纷争：一种灭活疫苗怎么会含有天然疾病呢？
West J Med. 1999 Oct;171(4):271-3.
10
Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine.在先前接种灭活脊髓灰质炎疫苗后口服脊髓灰质炎疫苗免疫期间强毒性脊髓灰质炎病毒回复株的脱落。
J Infect Dis. 1993 Nov;168(5):1105-9. doi: 10.1093/infdis/168.5.1105.
引用本文的文献
1
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.支持全球消灭脊髓灰质炎的脊髓灰质炎病毒传播综述与经济建模：2020 - 2024年
Pathogens. 2024 May 22;13(6):435. doi: 10.3390/pathogens13060435.
2
Older adults: panoramic view on the COVID-19 vaccination.老年人：关于新冠疫苗接种的全景视角
AIMS Public Health. 2021 May 8;8(3):388-415. doi: 10.3934/publichealth.2021030. eCollection 2021.
3
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden.瑞典曾接种过灭活脊髓灰质炎疫苗的成年人对口服减毒活脊髓灰质炎病毒疫苗激发试验的肠道抗体反应
BMJ Glob Health. 2019 Aug 28;4(4):e001613. doi: 10.1136/bmjgh-2019-001613. eCollection 2019.
4
Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants.口服脊髓灰质炎减毒活疫苗序贯三价灭活脊髓灰质炎疫苗/二价口服脊髓灰质炎疫苗与三价灭活脊髓灰质炎疫苗免疫程序后对脊髓灰质炎病毒的肠道免疫：智利婴儿开放性、随机、对照试验分析。
Clin Infect Dis. 2018 Oct 30;67(suppl_1):S42-S50. doi: 10.1093/cid/ciy603.
本文引用的文献
1
Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.在多米尼加共和国的幼儿中，三种氢氧化铝佐剂灭活脊髓灰质炎疫苗（IPV-Al）与标准IPV相比，剂量降低后的免疫原性和安全性：一项2期、非劣效性、观察者盲法、随机和对照剂量研究试验。
Lancet Infect Dis. 2017 Jul;17(7):745-753. doi: 10.1016/S1473-3099(17)30177-9. Epub 2017 Apr 25.
2
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.疫苗诱导的针对脊髓灰质炎病毒的黏膜免疫：对拉丁美洲婴儿一项开放标签随机对照试验队列的分析
Lancet Infect Dis. 2016 Dec;16(12):1377-1384. doi: 10.1016/S1473-3099(16)30169-4. Epub 2016 Sep 13.
3
Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign - Telangana State, India, June 2016.2016 年 6 月，印度特伦甘纳邦开展了口服脊髓灰质炎疫苗（减毒）分剂次免疫接种活动。
MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):859-63. doi: 10.15585/mmwr.mm6533a5.
4
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.新双价口服脊髓灰质炎疫苗免疫程序和一剂或两剂灭活脊髓灰质炎疫苗在拉丁美洲婴儿中诱导的体液和肠道免疫：一项开放标签随机对照试验。
Lancet. 2016 Jul 9;388(10040):158-69. doi: 10.1016/S0140-6736(16)00703-0. Epub 2016 May 19.
5
Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial.新型单价高剂量2型灭活脊髓灰质炎疫苗在婴儿中的免疫原性和安全性：一项比较、观察者盲法、随机、对照试验
Lancet Infect Dis. 2016 Mar;16(3):321-30. doi: 10.1016/S1473-3099(15)00488-0. Epub 2015 Dec 21.
6
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.在智利婴儿中单独使用或与二价口服脊髓灰质炎疫苗序贯使用灭活脊髓灰质炎病毒疫苗：一项随机、对照、开放性标签、四期、非劣效性研究。
Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26.
7
Polio eradication. Efficacy of inactivated poliovirus vaccine in India.脊髓灰质炎（小儿麻痹症）消除。印度灭活脊髓灰质炎病毒疫苗的效力。
Science. 2014 Aug 22;345(6199):922-5. doi: 10.1126/science.1255006.
8
Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial.单剂灭活脊灰疫苗对先前口服脊灰疫苗儿童肠道脊灰病毒免疫力的影响：一项开放标签、随机对照试验。
Lancet. 2014 Oct 25;384(9953):1505-12. doi: 10.1016/S0140-6736(14)60934-X. Epub 2014 Jul 10.
9
Poliovirus vaccination options for achieving eradication and securing the endgame.脊灰病毒疫苗接种选项，以实现根除并确保终局之战。
Curr Opin Virol. 2013 Jun;3(3):309-15. doi: 10.1016/j.coviro.2013.05.007. Epub 2013 Jun 10.
10
Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.口服及灭活脊髓灰质炎疫苗诱导黏膜免疫对口服脊髓灰质炎病毒攻击后病毒脱落的影响：系统评价
PLoS Pathog. 2012;8(4):e1002599. doi: 10.1371/journal.ppat.1002599. Epub 2012 Apr 19.
Zotero 插件